cisapride has been researched along with Weight Gain in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Weight Gain: Increase in BODY WEIGHT over existing weight.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of cisapride, 10 mg three times daily, in improving gastric emptying, reducing distress during meals, and facilitating weight gain in anorexia nervosa, we conducted an 8-week, randomized, double-blind, placebo-controlled trial on 29 inpatients." | 9.08 | A controlled trial of cisapride in anorexia nervosa. ( Binns, DS; Lichtenstein, M; Miller, G; Szmukler, GI; Young, GP, 1995) |
| "To determine the efficacy of cisapride, 10 mg three times daily, in improving gastric emptying, reducing distress during meals, and facilitating weight gain in anorexia nervosa, we conducted an 8-week, randomized, double-blind, placebo-controlled trial on 29 inpatients." | 5.08 | A controlled trial of cisapride in anorexia nervosa. ( Binns, DS; Lichtenstein, M; Miller, G; Szmukler, GI; Young, GP, 1995) |
| "Visceral myopathy is one of the causes of chronic intestinal pseudo-obstruction." | 2.52 | Abnormal layering of muscularis propria as a cause of chronic intestinal pseudo-obstruction: A case report and literature review. ( Angkathunyakul, N; Molagool, S; Ruangwattanapaisarn, N; Treepongkaruna, S, 2015) |
| "Weight gain was significant and recurrent cough and wheeze disappeared." | 1.28 | New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. ( Dab, I; Malfroot, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angkathunyakul, N | 1 |
| Treepongkaruna, S | 1 |
| Molagool, S | 1 |
| Ruangwattanapaisarn, N | 1 |
| Szmukler, GI | 1 |
| Young, GP | 1 |
| Miller, G | 1 |
| Lichtenstein, M | 1 |
| Binns, DS | 1 |
| Malfroot, A | 1 |
| Dab, I | 1 |
1 review available for cisapride and Weight Gain
| Article | Year |
|---|---|
Abnormal layering of muscularis propria as a cause of chronic intestinal pseudo-obstruction: A case report and literature review.
Topics: Biomarkers; Biopsy; Brachydactyly; Chronic Disease; Cisapride; Digestive System Abnormalities; Enter | 2015 |
1 trial available for cisapride and Weight Gain
| Article | Year |
|---|---|
A controlled trial of cisapride in anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Cisapride; Dose-Response Relationship, Drug; Double-Blind Metho | 1995 |
1 other study available for cisapride and Weight Gain
| Article | Year |
|---|---|
New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.
Topics: Child, Preschool; Cisapride; Cough; Cystic Fibrosis; Female; Follow-Up Studies; Gastroesophageal Ref | 1991 |